Takeda Shows Signs Of Undergoing Corporate Shift In Decision-making
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Takeda has incrementally made a number of organizational announcements in recent months hinting at a shift in the company's outlook to R&D investment and alliance-building in new markets